Beijing SL Pharmaceutical Co Ltd (002038) — Cash Flow-to-Debt Ratio
Beijing SL Pharmaceutical Co Ltd (002038) has a Cash Flow-to-Debt Ratio of 0.20x as of September 2025, meaning its operating cash flow of CN¥66.55 Million could theoretically repay 0% of its total liabilities (CN¥327.96 Million) in one year. See 002038 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing SL Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Beijing SL Pharmaceutical Co Ltd across 23 annual periods. Also explore 002038 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Beijing SL Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Beijing SL Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 002038 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥257.66 Million | CN¥883.49 Million | ▼ -48.5% |
| 2024 | 0.57x | CN¥225.49 Million | CN¥398.37 Million | ▼ -42.5% |
| 2023 | 0.98x | CN¥460.20 Million | CN¥467.72 Million | ▲ +0.1% |
| 2022 | 0.98x | CN¥389.82 Million | CN¥396.60 Million | ▼ -8.1% |
| 2021 | 1.07x | CN¥464.63 Million | CN¥434.23 Million | ▲ +5.5% |
| 2020 | 1.01x | CN¥415.84 Million | CN¥410.09 Million | ▼ -38.5% |
| 2019 | 1.65x | CN¥665.83 Million | CN¥403.76 Million | ▲ +59.7% |
| 2018 | 1.03x | CN¥485.17 Million | CN¥469.73 Million | ▼ -22.5% |
| 2017 | 1.33x | CN¥380.72 Million | CN¥285.67 Million | ▼ -49.2% |
| 2016 | 2.62x | CN¥396.86 Million | CN¥151.19 Million | ▼ -22.8% |
| 2015 | 3.40x | CN¥504.87 Million | CN¥148.40 Million | ▲ +0.9% |
| 2014 | 3.37x | CN¥465.00 Million | CN¥137.92 Million | ▲ +19.5% |
| 2013 | 2.82x | CN¥347.41 Million | CN¥123.09 Million | ▼ -25.5% |
| 2012 | 3.79x | CN¥398.60 Million | CN¥105.17 Million | ▼ -16.2% |
| 2011 | 4.53x | CN¥228.59 Million | CN¥50.52 Million | ▼ -29.3% |
| 2010 | 6.40x | CN¥238.13 Million | CN¥37.22 Million | ▲ +34.8% |
| 2009 | 4.75x | CN¥174.41 Million | CN¥36.75 Million | ▼ -36.7% |
| 2008 | 7.50x | CN¥194.32 Million | CN¥25.91 Million | ▲ +194.6% |
| 2007 | 2.55x | CN¥88.36 Million | CN¥34.71 Million | ▲ +56.6% |
| 2006 | 1.63x | CN¥57.55 Million | CN¥35.41 Million | ▼ -19.8% |
| 2005 | 2.03x | CN¥47.48 Million | CN¥23.42 Million | ▲ +84.0% |
| 2004 | 1.10x | CN¥31.26 Million | CN¥28.38 Million | ▲ +32.6% |
| 2003 | 0.83x | CN¥30.55 Million | CN¥36.78 Million | — |